UK markets closed
NIKKEI 225
38,073.98 -128.42 (-0.34%) HANG SENG
18,537.81 +223.91 (+1.22%) CRUDE OIL
79.67 +0.41 (+0.52%) GOLD FUTURES
2,352.80 +12.50 (+0.53%) DOW
39,387.76 +331.36 (+0.85%) Bitcoin GBP
50,576.11 +1,690.57 (+3.46%)
Praxis Precision Medicines, Inc. (PRAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 50.75 |
| Open | 50.93 |
| Bid | 49.60 x 100 |
| Ask | 50.44 x 100 |
| Day's range | 49.52 - 50.93 |
| 52-week range | 12.45 - 67.21 |
| Volume | |
| Avg. volume | 214,518 |
| Market cap | 856.93M |
| Beta (5Y monthly) | 2.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Wall Street Analysts See a 144.74% Upside in Praxis Precision Medicines (PRAX): Can the Stock Really Move This High?
The consensus price target hints at a 144.7% upside potential for Praxis Precision Medicines (PRAX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Zacks
Praxis Precision Medicines (PRAX) Upgraded to Buy: Here's Why
Praxis Precision Medicines (PRAX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX) gain from positive study updates.
© 2024 Yahoo. All rights reserved.